NDC 72934-1018

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.1%

Benzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.1%

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.1% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Benzoyl Peroxide; Niacinamide; Clindamycin Phosphate; Tretinoin.

Product ID72934-1018_87fd503e-c4f4-368e-e053-2995a90ac27e
NDC72934-1018
Product TypeHuman Prescription Drug
Proprietary NameBENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.1%
Generic NameBenzoyl Peroxide 5% / Clindamycin 1% / Niacinamide 2% / Tretinoin 0.1%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-04
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameBENZOYL PEROXIDE; NIACINAMIDE; CLINDAMYCIN PHOSPHATE; TRETINOIN
Active Ingredient Strength5 g/100g; g/100g; g/100g; g/100g
Pharm ClassesDecreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Retinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1018-2

30 g in 1 BOTTLE, PUMP (72934-1018-2)
Marketing Start Date2019-05-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1018-2 [72934101802]

BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.1% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-04

Drug Details

Active Ingredients

IngredientStrength
BENZOYL PEROXIDE5 g/100g

Pharmacological Class

  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Retinoid [EPC]
  • Retinoids [CS]
  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Retinoid [EPC]
  • Retinoids [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.